Monday, February 15, 2016

Experts Respond to FDA's Opioid Action Plan

(MedPage Today) -- Changes to risk-benefit paradigm, more advisory meetings, new labeling -- will it work?
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)